NICE Issues Final Guidance on Dronedarone
This is a discussion on NICE Issues Final Guidance on Dronedarone within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The drug is allowed for second-line use in patients with additional cardiovascular risk factors. Heartwire More......
|
|||||||
| Register | Help | Members List | Mark Forums Read |
07-20-2010, 05:06 PM
|
|||
|
|||
NICE Issues Final Guidance on Dronedarone
The drug is allowed for second-line use in patients with additional cardiovascular risk factors.
Heartwire More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| UK NICE Issues Guidance on VTE Prevention | industry_news | Other Clinical Pharmacy News | 0 | 02-12-2010 11:23 PM |
| UK Cardiologists Petition NICE to Reverse Dronedarone Decision | industry_news | Other Clinical Pharmacy News | 0 | 02-04-2010 07:32 PM |
| NICE Leans Away from Dronedarone for Atrial Fib | industry_news | Other Clinical Pharmacy News | 0 | 12-30-2009 05:16 PM |
| NICE Issues Guidance on Two Injectable AMD Products Approved by the FDA | diana.papshev | Updates from the Technology Assessment Authorities | 0 | 08-28-2008 12:18 PM |
| NICE issues guidance on sequential use of anti-TNFs | diana.papshev | Updates from the Technology Assessment Authorities | 0 | 07-22-2008 05:48 PM |
© 2008 DrugManagementForum™ powered by |
 |